DIETARY INFLAMMATORY POTENTIAL AND FOOD PATTERNS IN RELATION TO GUT MICROBIOME AMONG CHILDREN WITH CROHN’S DISEASE: A COMPARATIVE STUDY WITH HEALTHY CONTROLS

2021 ◽  
Vol 27 (Supplement_1) ◽  
pp. S39-S40
Author(s):  
Jessica Breton ◽  
Vincent Tu ◽  
Ceylan Tanes ◽  
Ryan Quinn ◽  
Maire Conrad ◽  
...  

Abstract Introduction The microbiome has been suggested to play an important role in the pathogenesis and progression of Crohn’s disease (CD) with the components of a Western diet, in turn, potentially altering the gut microbiome. We conducted an observational study comparing dietary influences on the gut microbiota in children with active or quiescent CD with healthy controls. Method A prospective cross-sectional study including 58 children with CD (36 with clinically active disease, PCDAI>10) between 6 and 21 years of age and 56 healthy controls was conducted. Dietary intake was estimated using a 3 day dietary recall. The following measurements were selected to assess diet quality based on 1) consumption measured against the American Dietary Guidelines (HEI-2015) (a higher score over 100 representing a healthier diet) and 2) inflammatory potential (DII) (a higher score representing a more pro-inflammatory diet). Compositional and functional analysis of the fecal microbiome was performed using shotgun metagenomics DNA sequencing and associations with dietary indices was modelled with linear mixed-effects models after controlling for confounding effects. Results Energy and dietary intakes between the healthy and CD cohorts were similar with the exception of fiber intake (%DRI), which was significantly lower in children with active CD than healthy controls (41.4 vs. 50.4, P=0.03). A similarly low total HEI-2015 score was found in patients with active and quiescent CD in comparison to healthy controls respectively (47.6 vs. 51.0 vs. 49.7, P= 0.41). A pro-inflammatory total DII score was found in all three groups (0.48 vs. 0.41 vs. 0.51, P=0.87). At the microbiome level, HEI-2015 (P=0.009) and DII (P= 0.024) showed significant positive and negative correlations with alpha-diversity, respectively, in children with quiescent CD only (Figure 1). In children with active CD, Proteobacteria Enterobacteriaceae displayed a significant positive correlation with DII (P= 0.006) (Figure 2), where a more pro-inflammatory DII score correlated with higher Escherichia coli relative abundances (P= 0.006). Conclusions To our knowledge, this is the largest study assessing dietary indices to evaluate the effects of diet quality on the gut microbiome in children with CD. Our results suggest important differential dietary influences on the gut microbiome according to clinical disease status in comparison to healthy children, with low quality diet and higher pro-inflammatory potential being associated with overall lower microbiome diversity in inactive CD and an enrichment in Proteobacteria, specifically E. coli, in children with active CD. Current ongoing functional analyses, including metabolomics, will shed light on the underlying diet-microbiota interactions implicated in CD and potentially assist clinical nutrition guidance and development of new dietary therapeutic trials.

2021 ◽  
Vol 160 (6) ◽  
pp. S-566
Author(s):  
Jessica Breton ◽  
Vincent Tu ◽  
Ceylan Tanes ◽  
Maire A. Conrad ◽  
Kelly Kachelries ◽  
...  

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S644-S644
Author(s):  
N Faqerah ◽  
Michael Logan ◽  
Richard Russell ◽  
Konstantinos Gerasimidis ◽  
Daniel Walker

Abstract Background The ability of adherent-invasive E. coli (AIEC), to adhere and invade intestinal epithelial cells and survive autophagy implicates them in the pathogenesis of Crohn’s disease (CD). Previous studies focused mostly on differences in the abundance of E. coli between patients with CD and healthy controls. Here, we studied changes in E. coli levels, E. coli strains and their ability to utilise carbon sources during treatment with exclusive enteral nutrition (EEN), at food reintroduction, and compared with healthy controls. Methods E. coli strains were isolated from culturing stool samples of twelve children with CD before and during induction treatment with EEN and following that, at food reintroduction. 10 healthy children acted as controls. 69 samples (CD, n = 59; healthy children, n = 10) were investigated in total. Absolute concentration of E. coli was measured with qPCR, changes in E. coli strains using colicin sensitivity spot tests and their ability to utilise carbon sources with Biolog phenotype microarrays. Results There was no significant change in the absolute levels of E. coli in patients with CD before or during EEN, and after food reintroduction. In comparison to healthy children, patients with CD had significantly higher levels of E. coli (p-value= 0.001). There were changes in E. coli at a strain-level in nine out of twelve CD patients as tested using colicin sensitivity tests before, during EEN, and after food reintroduction. Biolog microarrays showed a significant difference in E. coli community utilisation of 17 carbon sources in CD patients at different time points. Utilisation of polysaccharides, D-cellobiose, sucrose, and D-raffinose was increased during EEN compared with treatment initiation and after treatment cessation, at food reintroduction. In contrast, there was a significant reduction in utilisation for L-fucose and L-Rhamnose monosaccharides, sugar alcohols like D-glucose 6-PO4, and fatty acids such as propionic acid and acetoacetic acid by the end of EEN compared with treatment initiation and at reintroduction of habitual diet. In comparison to healthy controls, E. coli utilisation of different carbon sources in patients with CD was significantly different compared with CD patients during EEN only. Conclusion Children with CD experience changes in E. coli strains and in their ability to utilise certain carbon sources during treatment with EEN and compared with healthy controls. Analysis of strain-level metagenomic data will provide a comprehensive depiction of changes in E. coli population during EEN and compared with the healthy status.


Gut Pathogens ◽  
2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Shijia Hu ◽  
Eileen Png ◽  
Michelle Gowans ◽  
David E. H. Ong ◽  
Paola Florez de Sessions ◽  
...  

Abstract Background This study aims to characterize, the gut and oral microbiome in Asian subjects with Crohn’s disease (CD) using whole genome shotgun sequencing, thereby allowing for strain-level comparison. Methods A case–control study with age, sex and ethnicity matched healthy controls was conducted. CD subjects were limited to well-controlled patients without oral manifestations. Fecal and saliva samples were collected for characterization of gut and oral microbiome respectively. Microbial DNA were extracted, libraries prepared and sequenced reads profiled. Taxonomic diversity, taxonomic association, strain typing and microbial gene pathway analyses were conducted. Results The study recruited 25 subjects with CD and 25 healthy controls. The oral microbe Streptococcus salivarius was found to be enriched and of concordant strains in the gut and oral microbiome of Crohn’s disease subjects. This was more likely in CD subjects with higher Crohn’s Disease Activity Index (184.3 ± 2.9 vs 67.1 ± 82.5, p = 0.012) and active disease status (Diarrhoea/abdominal pain/blood-in-stool/fever and fatigue) (p = 0.016). Gut species found to be significantly depleted in CD compared to control (Relative abundance: Median[Range]) include: Faecalibacterium prausnitzii (0.03[0.00–4.56] vs 13.69[5.32–18.71], p = 0.010), Roseburia inulinivorans (0.00[0.00–0.03] vs 0.21[0.01–0.53], p = 0.010) and Alistipes senegalensis (0.00[0.00–0.00] vs 0.00[0.00–0.02], p = 0.029). While Clostridium nexile (0.00[0.00–0.12] vs 0.00[0.00–0.00], p = 0.038) and Ruminococcus gnavus (0.43[0.02–0.33] vs 0.00[0.00–0.13], p = 0.043) were found to be enriched. C. nexile enrichment was not found in CD subjects of European descent. Microbial arginine (Linear-discriminant-analysis: 3.162, p = 0.001) and isoprene (Linear-discriminant-analysis: 3.058, p < 0.001) pathways were found at a higher relative abundance level in gut microbiome of Crohn’s disease. Conclusions There was evidence of ectopic gut colonization by oral bacteria, especially during the active phase of CD. Previously studied gut microbial differences were detected, in addition to novel associations which could have resulted from geographical/ethnic differences to subjects of European descent. Differences in microbial pathways provide possible targets for microbiome modification.


2021 ◽  
Author(s):  
Yonglei Wu ◽  
Yijie Chen ◽  
Haolin Chen ◽  
Chenjie Yang ◽  
Xizhong Shen ◽  
...  

Serum N-glycan patterns from 50 Crohn‘s disease (CD) patients and 50 healthy controls were acquired by a carbon matrix-based platform. According to statistical analysis, eight specific N-glycans revealed remarkable performance for CD diagnosis.


2011 ◽  
Vol 5 (3) ◽  
pp. 411-425 ◽  
Author(s):  
Amy C Brown ◽  
S Devi Rampertab ◽  
Gerard E Mullin

2014 ◽  
Vol 103 (2) ◽  
pp. e55-e60 ◽  
Author(s):  
Jehlicka Petr ◽  
Huml Michal ◽  
Schwarz Jan ◽  
Trefil Ladislav ◽  
Kobr Jiri ◽  
...  

Author(s):  
Xin Fang ◽  
Yoshiki Vázquez-Baeza ◽  
Emmanuel Elijah ◽  
Fernando Vargas ◽  
Gail Ackermann ◽  
...  

Abstract Background Many studies have investigated the role of the microbiome in inflammatory bowel disease (IBD), but few have focused on surgery specifically or its consequences on the metabolome that may differ by surgery type and require longitudinal sampling. Our objective was to characterize and contrast microbiome and metabolome changes after different surgeries for IBD, including ileocolonic resection and colectomy. Methods The UC San Diego IBD Biobank was used to prospectively collect 332 stool samples from 129 subjects (50 ulcerative colitis; 79 Crohn’s disease). Of these, 21 with Crohn’s disease had ileocolonic resections, and 17 had colectomies. We used shotgun metagenomics and untargeted liquid chromatography followed by tandem mass spectrometry metabolomics to characterize the microbiomes and metabolomes of these patients up to 24 months after the initial sampling. Results The species diversity and metabolite diversity both differed significantly among groups (species diversity: Mann-Whitney U test P value = 7.8e-17; metabolomics, P-value = 0.0043). Escherichia coli in particular expanded dramatically in relative abundance in subjects undergoing surgery. The species profile was better able to classify subjects according to surgery status than the metabolite profile (average precision 0.80 vs 0.68). Conclusions Intestinal surgeries seem to reduce the diversity of the gut microbiome and metabolome in IBD patients, and these changes may persist. Surgery also further destabilizes the microbiome (but not the metabolome) over time, even relative to the previously established instability in the microbiome of IBD patients. These long-term effects and their consequences for health outcomes need to be studied in prospective longitudinal trials linked to microbiome-involved phenotypes.


Sign in / Sign up

Export Citation Format

Share Document